{"id":{"repo_id":"cornell","oai_identifier":"oai:ecommons.cornell.edu:1813/117122"},"canonical_url":"https://search.dev.ndltd.org/etd/cornell/oai:ecommons.cornell.edu:1813/117122","repository":{"repo_id":"cornell","name":"Cornell University","base_url":"https://ecommons.cornell.edu/server/oai/request"},"display":{"title":"AQP1—A REGULATORY FACTOR ASSOCIATED WITH BROWN ADIPOSE TISSUE SILENCING TO COMBAT OBESITY AND METABOLIC DISEASE","abstract":"The activation of non-shivering thermogenesis (NST) in brown adipose tissue (BAT) by environmental cold challenge yields strong metabolic benefit in the face of diet-induced obesity (DIO). Yet, a critical barrier to leveraging brown fat NST for therapeutic use against metabolic disease is that BAT is silenced and inactive at physiological ambient temperature conditions in humans and the mechanisms that govern this silencing process remain poorly understood. Here, I present a putative BAT-silencing factor, aquaporin-1 (AQP1), as a novel therapeutic target to protect subjects against DIO and metabolic dysfunction. Interrogation of in vivo metabolic parameters revealed BAT-specific AQP1 knockout mice (AQP1-KO) on high fat diet (HFD) experienced reduced diet-induced weight gain and fat mass, improved glucose tolerance, and increased whole body energy expenditure compared to control mice. Mechanistically, AQP1 ablation in mice on HFD had upregulated gene expression related to the electron transport chain (ETC) and mitochondrial translation. Thus, I demonstrate that ablation of AQP1 in BAT protects mice against DIO by increasing whole body energy expenditure through upregulation of the core ETC and mitochondrial translation gene program. My findings identify AQP1 as a novel regulatory factor that plays a potent role in modulating BAT metabolism and curbing the growing obesity epidemic in the United States.","abstract_html":"The activation of non-shivering thermogenesis (NST) in brown adipose tissue (BAT) by environmental cold challenge yields strong metabolic benefit in the face of diet-induced obesity (DIO). Yet, a critical barrier to leveraging brown fat NST for therapeutic use against metabolic disease is that BAT is silenced and inactive at physiological ambient temperature conditions in humans and the mechanisms that govern this silencing process remain poorly understood. Here, I present a putative BAT-silencing factor, aquaporin-1 (AQP1), as a novel therapeutic target to protect subjects against DIO and metabolic dysfunction. Interrogation of in vivo metabolic parameters revealed BAT-specific AQP1 knockout mice (AQP1-KO) on high fat diet (HFD) experienced reduced diet-induced weight gain and fat mass, improved glucose tolerance, and increased whole body energy expenditure compared to control mice. Mechanistically, AQP1 ablation in mice on HFD had upregulated gene expression related to the electron transport chain (ETC) and mitochondrial translation. Thus, I demonstrate that ablation of AQP1 in BAT protects mice against DIO by increasing whole body energy expenditure through upregulation of the core ETC and mitochondrial translation gene program. My findings identify AQP1 as a novel regulatory factor that plays a potent role in modulating BAT metabolism and curbing the growing obesity epidemic in the United States.","abstract_has_math":false,"creators":["Cheng, Chloe"],"institution":"Cornell University","degree_name":"Ph. D., Biomedical and Biological Sciences","degree_level":"Doctor of Philosophy","degree_discipline":"Biomedical and Biological Sciences","degree_department":null,"school":null,"contributors":[],"advisors":[],"committee_chairs":[],"committee_members":["Schimenti, John","Sethupathy, Praveen","Lujan, Marla"],"year":2024,"date_issued":"2024-12","date_published":"2024-12","updated_at":"2026-07-24T01:49:02Z","subjects":["Aquaporin","Brown Adipose Tissue","Metabolic Dysfunction","Negative Regulators","Obesity","Thermogenic Silencing"],"languages":["en"],"rights":["Attribution-NonCommercial-NoDerivatives 4.0 International"],"rights_urls":["https://creativecommons.org/licenses/by-nc-nd/4.0/"],"identifier_entries":[{"key":"dc:identifier.doi","label":"DOI","values":["http://doi.org/10.7298/6jhn-cx64"],"render_values":[{"text":"http://doi.org/10.7298/6jhn-cx64","href":"http://doi.org/10.7298/6jhn-cx64","code":true}]},{"key":"dc:identifier.other","label":"Dc Identifier Other","values":["ProQuest Submission ID: 14725","ProQuest Publication ID: 31639364"],"render_values":[{"text":"ProQuest Submission ID: 14725","href":null,"code":true},{"text":"ProQuest Publication ID: 31639364","href":null,"code":true}]}]},"links":{"outbound_url":"https://hdl.handle.net/1813/117122","outbound_label":"Handle","outbound_source":"dc:identifier.uri"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor.committeemember","label":"Committee Member","values":["Schimenti, John","Sethupathy, Praveen","Lujan, Marla"]},{"key":"dc:creator","label":"Author","values":["Cheng, Chloe"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.accessioned","label":"Dc Date Accessioned","values":["2025-06-30T22:02:40Z"]},{"key":"dc:date.available","label":"Dc Date Available","values":["2025-06-30T22:02:40Z"]},{"key":"dc:date.issued","label":"Date","values":["2024-12"]},{"key":"dc:type","label":"Dc Type","values":["dissertation or thesis"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["Biomedical and Biological Sciences"]},{"key":"thesis:degree_level","label":"Degree Level","values":["Doctor of Philosophy"]},{"key":"thesis:degree_name","label":"Degree Name","values":["Ph. D., Biomedical and Biological Sciences"]},{"key":"thesis:institution_name","label":"Thesis Institution Name","values":["Cornell University"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Aquaporin","Brown Adipose Tissue","Metabolic Dysfunction","Negative Regulators","Obesity","Thermogenic Silencing"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language.iso","label":"Language (ISO)","values":["en"]},{"key":"dc:rights","label":"Dc Rights","values":["Attribution-NonCommercial-NoDerivatives 4.0 International"]},{"key":"dc:rights.uri","label":"Rights URI","values":["https://creativecommons.org/licenses/by-nc-nd/4.0/"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier.doi","label":"DOI","values":["http://doi.org/10.7298/6jhn-cx64"]},{"key":"dc:identifier.other","label":"Dc Identifier Other","values":["ProQuest Submission ID: 14725","ProQuest Publication ID: 31639364"]},{"key":"dc:identifier.uri","label":"Identifier URI","values":["https://hdl.handle.net/1813/117122"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description","label":"Description","values":["116 pages"]},{"key":"dc:description.abstract","label":"Abstract","values":["The activation of non-shivering thermogenesis (NST) in brown adipose tissue (BAT) by environmental cold challenge yields strong metabolic benefit in the face of diet-induced obesity (DIO). Yet, a critical barrier to leveraging brown fat NST for therapeutic use against metabolic disease is that BAT is silenced and inactive at physiological ambient temperature conditions in humans and the mechanisms that govern this silencing process remain poorly understood. Here, I present a putative BAT-silencing factor, aquaporin-1 (AQP1), as a novel therapeutic target to protect subjects against DIO and metabolic dysfunction. Interrogation of in vivo metabolic parameters revealed BAT-specific AQP1 knockout mice (AQP1-KO) on high fat diet (HFD) experienced reduced diet-induced weight gain and fat mass, improved glucose tolerance, and increased whole body energy expenditure compared to control mice. Mechanistically, AQP1 ablation in mice on HFD had upregulated gene expression related to the electron transport chain (ETC) and mitochondrial translation. Thus, I demonstrate that ablation of AQP1 in BAT protects mice against DIO by increasing whole body energy expenditure through upregulation of the core ETC and mitochondrial translation gene program. My findings identify AQP1 as a novel regulatory factor that plays a potent role in modulating BAT metabolism and curbing the growing obesity epidemic in the United States."]},{"key":"dc:format.mimetype","label":"Dc Format Mimetype","values":["application/pdf"]},{"key":"dc:title","label":"Title","values":["AQP1—A REGULATORY FACTOR ASSOCIATED WITH BROWN ADIPOSE TISSUE SILENCING TO COMBAT OBESITY AND METABOLIC DISEASE"]}]}],"canonical_facts":{"dc:contributor.committeemember":["Schimenti, John","Sethupathy, Praveen","Lujan, Marla"],"dc:creator":["Cheng, Chloe"],"dc:date.accessioned":["2025-06-30T22:02:40Z"],"dc:date.available":["2025-06-30T22:02:40Z"],"dc:date.issued":["2024-12"],"dc:description":["116 pages"],"dc:description.abstract":["The activation of non-shivering thermogenesis (NST) in brown adipose tissue (BAT) by environmental cold challenge yields strong metabolic benefit in the face of diet-induced obesity (DIO). Yet, a critical barrier to leveraging brown fat NST for therapeutic use against metabolic disease is that BAT is silenced and inactive at physiological ambient temperature conditions in humans and the mechanisms that govern this silencing process remain poorly understood. Here, I present a putative BAT-silencing factor, aquaporin-1 (AQP1), as a novel therapeutic target to protect subjects against DIO and metabolic dysfunction. Interrogation of in vivo metabolic parameters revealed BAT-specific AQP1 knockout mice (AQP1-KO) on high fat diet (HFD) experienced reduced diet-induced weight gain and fat mass, improved glucose tolerance, and increased whole body energy expenditure compared to control mice. Mechanistically, AQP1 ablation in mice on HFD had upregulated gene expression related to the electron transport chain (ETC) and mitochondrial translation. Thus, I demonstrate that ablation of AQP1 in BAT protects mice against DIO by increasing whole body energy expenditure through upregulation of the core ETC and mitochondrial translation gene program. My findings identify AQP1 as a novel regulatory factor that plays a potent role in modulating BAT metabolism and curbing the growing obesity epidemic in the United States."],"dc:format.mimetype":["application/pdf"],"dc:identifier.doi":["http://doi.org/10.7298/6jhn-cx64"],"dc:identifier.other":["ProQuest Submission ID: 14725","ProQuest Publication ID: 31639364"],"dc:identifier.uri":["https://hdl.handle.net/1813/117122"],"dc:language.iso":["en"],"dc:rights":["Attribution-NonCommercial-NoDerivatives 4.0 International"],"dc:rights.uri":["https://creativecommons.org/licenses/by-nc-nd/4.0/"],"dc:subject":["Aquaporin","Brown Adipose Tissue","Metabolic Dysfunction","Negative Regulators","Obesity","Thermogenic Silencing"],"dc:title":["AQP1—A REGULATORY FACTOR ASSOCIATED WITH BROWN ADIPOSE TISSUE SILENCING TO COMBAT OBESITY AND METABOLIC DISEASE"],"dc:type":["dissertation or thesis"],"thesis:degree_discipline":["Biomedical and Biological Sciences"],"thesis:degree_level":["Doctor of Philosophy"],"thesis:degree_name":["Ph. D., Biomedical and Biological Sciences"],"thesis:institution_name":["Cornell University"]},"updated_at":"2026-07-24T01:49:02Z"}